Arkolith/Insider Trading/PHAS/Form 4

Thorp Clay

DirectorPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed Aug 18, 2021
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2021Buy(P)10K$3.00$30K33K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001169245-21-000080) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML